Delivery Order SPE2DR25D1052-SPE2DR26F6CF2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for Rabavert rabies vaccine with diluents, with a ceiling value of $3,770.60. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is scheduled for completion by December 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $6,287.40. The delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-set-aside competitive award. The vaccine will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,519.20 for Rabavert rabies vaccine with diluents on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,406.00 for Rabavert rabies vaccine with diluents, with performance at the company's facility in Conshohocken, Pennsylvania. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 5, 2025. The delivery order represents a specific transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $18,728.13. The order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,095.80 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor and healthcare solutions provider. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $5,251.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents, with performance in Conshohocken, Pennsylvania and an ultimate completion date of December 2, 2025. This contract was awarded competitively with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $3,310.41 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $10,145.00 to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents. This competitively awarded, firm fixed-price delivery order was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $27,702.24 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on December 9, 2025, with completion anticipated by December 10, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a single delivery order issued under the company's larger indefinite delivery contract vehicle with...
- SPE2DR25D1052Indefinite Delivery Contract
- SPE2DR25D1052-SPE2DR26F6CF2Delivery Order
The Defense Logistics Agency awarded a $9,913.05 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of November 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Rabavert vaccine delivery supports the Defense Health Agency and other federal healthcare systems' immunization requirements and reflects AmerisourceBergen's established capability to fulfill federal medical procurement needs through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 11/25/25 |